The effect of erythropoietin on cognition in affective disorders -- Associations with baseline deficits and change in subjective cognitive complaints / Caroline Vintergaard Ott en European Neuropsychopharmacology, Año 2016 - Vol. 26 - No. 8 (Agosto)

Público ISBD [artículo]  inEuropean Neuropsychopharmacology > Año 2016 - Vol. 26 - No. 8 (Agosto) . - pp. 1264-1273 Título : The effect of erythropoietin on cognition in affective disorders -- Associations with baseline deficits and change in subjective cognitive complaints Tipo de documento: texto impreso Autores: Caroline Vintergaard Ott, Autor ; Maj Vinberg, Autor ; Lars Vedel Kessing, Autor Fecha de publicación: 2021 Artículo en la página: pp. 1264-1273 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastorno depresivo, Trastorno bipolar, Epoetina Alfa, Deterioro cognitivo, Poner en pantalla Resumen: This is a secondary data analysis from our erythropoietin (EPO) trials. We examine (I) whether EPO improves speed of complex cognitive processing across bipolar and unipolar disorder, (II) if objective and subjective baseline cognitive impairment increases patients׳ chances of treatment-efficacy and (III) if cognitive improvement correlates with better subjective cognitive function,... Link: ./index.php?lvl=notice_display&id=26518 [artículo] The effect of erythropoietin on cognition in affective disorders -- Associations with baseline deficits and change in subjective cognitive complaints [texto impreso] / Caroline Vintergaard Ott, Autor ; Maj Vinberg, Autor ; Lars Vedel Kessing, Autor . - 2021 . - pp. 1264-1273. Idioma : Inglés (eng) Idioma original : Inglés (eng) in European Neuropsychopharmacology > Año 2016 - Vol. 26 - No. 8 (Agosto) . - pp. 1264-1273 Palabras clave: Trastorno depresivo, Trastorno bipolar, Epoetina Alfa, Deterioro cognitivo, Poner en pantalla Resumen: This is a secondary data analysis from our erythropoietin (EPO) trials. We examine (I) whether EPO improves speed of complex cognitive processing across bipolar and unipolar disorder, (II) if objective and subjective baseline cognitive impairment increases patients׳ chances of treatment-efficacy and (III) if cognitive improvement correlates with better subjective cognitive function,... Link: ./index.php?lvl=notice_display&id=26518

---

1 (1 - 1 / 1)